7p22.3 microdeletion: a case study of a patient with congenital heart defect, neurodevelopmental delay and epilepsy

Background Chromosome 7 has regions enriched with low copy repeats (LCRs), which increase the likelihood of chromosomal microdeletion disorders. Documented microdeletion disorders on chromosome 7 include both well-known Williams syndrome and more rare cases. It is noteworthy that most cases of various microdeletions are characterized by phenotypic signs of neuropsychological developmental disorders, which, however, have a different genetic origin. The localization of the microdeletions, the genes included in the region, as well as the structural features of the sequences of these genes have a cumulative influence on the phenotypic characteristics of the individuals for each specific case and the severity of the manifestations of disorders. The consideration of these features and their detailed analysis is important for a correct and comprehensive assessment of the disease. Results The article describes a clinical case of 7p22.3 microdeletion in a patient with congenital heart defect and neurological abnormalities - epilepsy, combined with moderate mental and motor developmental delay. Conclusions Through detailed genetic analyses, we are improving the clinical description of the rare 7p22.3 microdeletion and thus creating a basis for future genetic counseling and research into targeted therapies.


Skvortsova et al. Orphanet Journal of Rare Diseases
(2024) 19:301 https://doi.org/10.1186/s13023-024-03321-8health complications depending on the genes affected.Some reported features associated with this microdeletion include developmental delays, intellectual disability, growth problems, and certain facial characteristics.The severity and combination of symptoms may differ, but neurodevelopment delays and heart defects are the most consistent features.Recently, Marbach F and colleagues reported direct evidence between the PRKAR1B gene, located on 7p22.3, and certain types of neurodevelopmental delays [1].The relationships between the 7p22.3microdeletion and heart defects are less clear than neurodevelopmental delays, and more research is needed to establish a specific correlation.The comparative analysis of published cases with the deletion in the 7p22.3

Background
A 7p22.3 microdeletion is a rare genetic condition where a small piece of chromosome 7 is missing.This deletion can result in various health issues depending on the specific genes that are involved.Microdeletion 7p22.3 is a rare genetic anomaly characterized by the absence of a segment on chromosome 7 and leads to various Orphanet Journal of Rare Diseases 7p22.3 microdeletion: a case study of a patient with congenital heart defect, neurodevelopmental delay and epilepsy Liliya Skvortsova 1 , Anastassiya Perfilyeva 1 , Kira Bespalova 1,2* , Yelena Kuzovleva 1 , Nailya Kabysheva 1 and Ozada Khamdiyeva 1,2  identified a minimal region causative for heart malformations [2,3].There are two potential candidate genes SNX8 and EIF3B responsible for the heart malformations development in this region.Involvement of these genes in cardiac embryonic development is not fully understood and requires additional experimental and clinical cases.
Here, we describe a one-year-old girl with a 2.4 Mb deletion at the 7p22.3locus involving 40 genes that shows learning and language delay, epilepsy, autism, hypotonia, dyspraxia and ventricular septal defect.

Clinical presentation and family history
The patient A is a 1 year 6 months old girl of Kazakh nationality, born to non consanguineous parents.The child from the 4th pregnancy of a mother with a history of endocrine disorder and apparently healthy father (Fig. 1).Body weight is 10 kg and height is 79 cm (Z-score = 0.1; percentile = 54.8), the head circumference is 44 cm (Z-score =−1.6; percentile = 5.3); her face and palpebral fissures are symmetrical, the tongue lies in the midline.Muscle tone is severely reduced symmetrically, relative to the sagittal axis (D = S).Muscle strength is reduced, support on the feet is weakened -support on the toes when standing.In addition, there is a developmental coordination disorder -dyspraxia.History of epileptic tonic seizures; remission for 6 months while taking the levetiracetam therapy.She does not chew solid food or drink from a cup (drink is squirted into her mouth with a syringe).
The contact is unproductive due to ignoring her name or requests/instructions; She doesn't make eye contact and her reaction of joint attention is negative.She is fenced off and extremely attached to her smartphone, in which she independently finds and plays fragments of cartoons.She is not interested in toys and prefers to manipulate non-play objects.Her emotions are inexpressive, monotonous and it is extremely difficult to attract her attention.She reacts positively only to a tactile stimulation, pronounces sounds and babbling elements without the purpose of the communication.Her behavior is autonomous.There are no self-service and neatness skills.

Birth, growth and neurologic history
The girl was born at 38 weeks of gestation via normal, spontaneous vaginal delivery.The birth weight was 2983 g and the length was 50 cm.She cried out immediately, the skin and limbs of her body were bluish in color and the Apgar score was 4-7 points.A diagnosis of congenital heart defect, ventricular septal defect (VSD) was verified.The child was breastfed from birth and showed difficulty in latching and sucking with subsequent vomiting and regurgitation.Due to the increased pulmonary hypertension, VSD surgery was done at the age of 2 months to correct a hole between the left and right ventricles of the heart.The thymus was removed during the VSD surgery.At 7 months of age, single tonic seizures appeared during teething and a low-grade fever.Subsequently, tonic seizures were noted at the body temperature of 38 °C (frequent acute respiratory viral infections due to removal of the thymus) in the form of prolonged tension in the limbs and increased sweating.The tonic febrile seizures did not disappear after the cessation of the underlying illness and epilepsy with tonic seizures were diagnosed by a neurologist.
The child began to hold her head at 4 months, to sit at 12 months, to crawl at 13 months and to walk with support at 15 months.Onomatopoeia was noted in the child from 6 months and babbling was noted from 10 months.The patient is the fourth child of four and her three siblings are unaffected (Fig. 1).The family lives in an environmentally unfavorable region of Kazakhstan, with high technogenic pollutants from industrial plants producing salt, coal and other minerals.

Chromosome microarray analysis (CMA)
The СMA was performed at the Centre for Molecular Medicine (Almaty, Kazakhstan).Array CGH was performed using 4 × 180 K microarrays from Oxford Gene Technology (CytoSure ISCA, v3, Oxford, UK).All genomic coordinates were based on the reference genome (NCBI37/hg19).Data analysis was performed using CytoSure Interpret Software (Oxford Gene Technology, Oxford, UK) and the circular binary segmentation algorithm.The calling thresholds were deviation of a circular binary segmentation (CBS) segment from zero log ratio of + 0.30 for duplications and−0.5 for deletions.The results were then classified using CytoSure Interpret Software (Oxford Gene Technology, Oxford, UK).Quality control metrics were monitored using CytoSure Interpret Software (Oxford Gene Technology).

DNA extraction
DNA was extracted with Promega Wizard™ Genomic DNA Purification Kits according to the manufacturer's protocol and quantified with Qubit.

Molecular cytogenetic examination
Given the severe early postnatal medical history and the presence of a number of congenital phenotypic characteristics, it was assumed that the patient had structural chromosomal rearrangements/chromosomal abnormalities.Chromosome microarray analysis (CMA) was performed to confirm the genetic alterations at the chromosomal level.Based on the CMA results, the patient's molecular karyotype arr[GRCh38] 7p22.3(XX)×1 was determined, confirming the presence of a microdeletion of 2,411,970 bp on the short arm of the chromosome 7 (Fig. 2).
The locus of imbalance includes 40 genes, which are shown in Fig. 3.In the Decipher and ClinVar databases, microdeletions of this region are described as likely pathogenic and/or variants of unknown clinical significance (VUS) in patients with minor anomalies, congenital defects and developmental delays.The detected microdeletion is not indexed in the DGV database of normal genomic variants.Microdeletions in this region are identified in the Orphanet database as a distal monosomy 7p (ORPHA:96126).Therefore, the identified microdeletion can be considered as VUS.

Diagnostic testing
At the age of 16 months, the patient A was referred for a diagnosis of orphan diseases by tandem mass spectrometry.According to the results, no abnormalities were found in the levels of amino acids, carnitines, lysophospholipids, nucleosides, ketones, or enzymes.
An additional test of the spectrum of organic acids in the urine using gas chromatography (60 indicators) to identify congenital metabolic disorders showed no deviations from normal values.

Whole exome sequencing
For a thorough analysis of the patient's genetic profile, whole exome sequencing (WES) was performed on patient A, as well as on their father, mother and healthy sister.A total of over 159 million reads were generated using an Illumina NovaSeq sequencer for the family of patient A, covering approximately 48,265,177,638 base pairs.Table 1 contains summarized statistics for all reads.Of these, 591,582 single nucleotide variations (SNVs) and 98,423 insertions/deletions (InDels) were identified, from which 475,093 SNVs and 90,042 InDels met the criteria for successful filtering.A total of 344 high confidence de novo mutations were detected, which were absent in the healthy sister but present in the patient A. A total of 4,901 variants corresponded to an autosomal recessive inheritance pattern.The variants were annotated and classified according to the standards of the American College of Medical Genetics and Genomics.All variants were assessed for evidence of pathogenicity in the Clin-Var database.No variants associated with the development of epilepsy in patient A were identified.

Discussion
Complex disease phenotypes affecting different organ systems are the result of an individual's complex genetic landscape.Analysis of the literature data shows that there is a certain variability of phenotypes even in Mendelian diseases.Symptoms may vary in the presence/absence and severity from patient to patient.These individual phenotypes are the most noticeable in microdeletion syndromes when multiple genes are affected.One of these syndromes is Williams syndrome, which is caused by a heterozygous deletion 7q11.23 [11,12].There are specific symptoms and features with a high frequency of occurrence (core symptoms, > 90% of cases) and less specific features with a frequency of < 90% (Morris 2023).The last ones are highly variable from patient to patient.This emphasizes that microdeletion syndromes are not a uniform disease but a group of etiologically heterogeneous conditions whose pathophysiology reflect an individual genetic profile.The functional activity of affected proteins and their involvement in cellular processes as well as the presence of additional structural changes in single-copy genes modulate a pathological phenotype.
In the present case, the patient A had most of the symptoms typical for Williams syndrome and was referred for a genetic counseling (to be confirmed by genetic testing).CMA revealed the absence of the specific microdeletion in the long arm of chromosome 7 (7q11.23)but the presence of another microdeletion in the short arm of chromosome 7 (7p22.3).The identified deletion is less common than the Williams syndrome deletion and some cases have been published.Deletion 7p22.3 phenotype is associated with various clinical symptoms including neurodevelopmental delay, congenital skeletal and heart abnormalities, hypotonia, craniofacial dysmorphism and other less common features [3].To date, epilepsy has not been reported for this 7p22.3deletion but it was observed in a patient with a combination of 7p22.3-p22.1 deletion and 8q24.23-q24.3duplication.In this case, the occurrence of epilepsy in a patient was apparently related to the KCNQ3 gene located within the 8q24.23-q24.3duplication [13].It is well known that genes encoding ion channels in the brain are dosage-sensitive genes and have dominant traits [14,15].In contrast, epilepsy was not observed in two siblings with large 7p22.3-p22.2and 15q11.1-q11.2deletions, emphasising the absence of epilepsy-related genes in the 7p22.3deletion region [16] In addition to epilepsy, the patient A had other symptoms not previously mentioned in the 7p22.3deletion, such as microcephaly, feeding problems and autistic traits.Further detailed analysis of the 7p22.3microdeletion region did not reveal any genes directly associated with these additional abnormalities (Table 2).
The patient has three main types of abnormalities: neurological development, epilepsy and cardiac malformation.We examined the role of each gene within the 7p22.3deletion to describe the complex phenotype of our case.
Neurological abnormalities such as developmental delay, hypotonia and apraxia/dyspraxia found in our patient may be described by the recently identified Marbach-Schaaf Neurodevelopmental Syndrome (MASNS) associated with the PRKAR1B gene [1].According to the case study by Marbach F et al., affected patients also exhibited behavioural abnormalities such as autistic and sensory-seeking behavioral.The diagnosis of autism spectrum disorder (ASD) and sensory processing disorder (sensation seeking) made by expert-physicians in our patient is consistent with these characteristics.PRKAR1B mutations found by Marbach F et al. are heterozygous and highlights the importance of the presence A developing brain is a sensitive organ that can be affected by various factors.Childhood febrile seizures and delayed neurological development are risk factors for the incidence of epilepsy [17].The mechanisms underlying this pathology are poorly understood but experimental data indicated the importance of inflammatory processes and their regulation in the brain [18,19].An up-regulation of inflammatory response pathways with subsequent activation of glial cells and astrocytes, as well as the production of pro-inflammatory cytokines and chemokines is observed.Additionally, neuroinflammation and the activation of the immune response caused by other neurological pathologies may be triggers for the development of epilepsy [20][21][22].By shifting the balance of the local membrane microenvironment, neuroinflammation changes the activity of ion channels that are important for both normal neuronal activity (synaptic transmission, excitation-inhibition balance) and the development of seizures (excitatory-inhibitory imbalance) [23,24].The genetic landscape of the affected ion channels and closely related proteins also contributes to the epileptic activity of neurons.
The coincidence of two processes associated with neuroinflammation in our patient -febrile seizures and congenital neurodevelopmental abnormalities -appear to be the main factors in the development of epilepsy.Notably, our WES analysis did not reveal any significant pathogenic mutations in epilepsy-related genes.It is likely that other more common nucleotide changes in these genes may be important in the aforementioned pathologies and predispose neurons to an excitatory-inhibitory imbalance.This question is complex and requires further research.
The literature data suggest that the 7p22.3locus is an important region for heart development, and case studies have reported congenital heart defects in patients with deletions of different sizes of 7p22.However, the specific genes responsible for the abnormal heart development are still under investigation and debate.The proposed candidate genes are SNX8 and EIF3B but their clinical and experimental data are controversial.The SNX8 protein belongs to a large family of proteins involved in intracellular endosome trafficking, sorting of various proteins and cellular homeostasis through the Golgi network [25,26].The importance of these proteins in pathologies is not fully understood but given their ubiquitous cytoplasmic expression and low tissue specificity they may have variable expressivity and/or reduced penetrance in different organs.This controversy has been noted in congenital heart defects in cases with different sizes of 7p22.3 deletions [27].A comparative analysis of published 7p22.3 deletion cases by Mastromoro G et al. [2] and Tessier A et al. [27] shows that SNX8 haploinsufficiency may be necessary but not a sufficient cause of heart malformations.Another candidate gene is the EIF3B gene, which encodes the subunit B of the eukaryotic translation initiation factor 3 (eIF3).EIF3 is the largest and most complex translation initiation factor for proteins' biosynthesis in cells and consists of 13 subunits (eIF3a-eIF3m) [28].Various incoming signals and controlled downstream target mRNAs for the translation initiation make this complex an essential regulator for the development and functioning of an organism.Given the important role of eIF3, mechanisms underlying various pathologies caused by insufficiency of the eIF3 complex have been the focus of attention for many years.In particular, different subunits have been associated with different processes: the subunit e (eIF4e) was found to be more important in embryonic development [29]; the subunit a (eIF3a) in the development of brain, lungs, fat, skin, spleen, and thymus [30]; the subunit b (eIF3b) in the development of heart and nervous system [31,32].The available experimental data on model organisms show that the complexity of the eIF3 interactions gradually increases through evolution.
Zebrafish experiments have shown that the lack of functional activity of the eif3ba protein (eIF3b, the human ortholog) most affects cranial neural crest development, leading to dramatic changes in the cranial neural crest cells (cNCCs) migration and derivative heart tissue development [33].Although these changes are compatible with embryonic development in zebrafish, they are lethal to post-embryonic development at day 5.For the most complex vertebrates like mice, the complete absence of the protein is lethal to the embryo at the blastocyst stage but its reduced activity was compatible with the embryonic development and not with the post embryonic development (6.5 days).
The role of cNCCs in heart formation is well established in mammalian development and abnormalities in cNCCs may affect a spectrum of congenital heart outflow tract defects (tetralogy of Fallot, ventricular septal defect, overriding aorta, double outlet of the right ventricle, persistent truncus arteriosus, and others [34,35].The question of how relevant downstream signaling pathways function when one copy of the eIF3b gene is lost remains open.Experimental evidence on mice suggests that heterozygosity of eif3b +/has no visual phenotypic abnormalities because the mice were successfully crossed and the offspring were obtained.Thus, the currently available studies do not allow to identify specific genes directly responsible for the development of heart pathologies in the presence of the microdeletion in the 7p22.3region.Additional molecular and genetic studies are required to clarify this relationship.Moreover, in our WES analysis, we focused on variants that directly alter the amino acid sequence of proteins and excluded variants in the splicing region, synonymous variants, intronic variants, upstream and downstream gene variants, intergenic variants, and variants in the regulatory region because it is extremely difficult to predict their functional effects.Predicting the effects of splice region variants is complex due to the complicated nature of splicing mechanisms and the involvement of multiple regulatory elements, which can lead to unreliable or false positive results [36].The functional effects of synonymous variants are also difficult to predict as they do not lead to corresponding protein sequence changes [37].The databases used to annotate these variants may not provide complete information, which increases the risk of misinterpretation [37].In addition, there is a problem that there are no truly negative variants, i.e. those that have been shown to have no effect on the protein function or no association with the disease [38].In addition, WES does not capture intronic and other non-exonic regions with the same depth, resulting in incomplete data for variants in splice regions and other non-coding variants.This limitation reduces the reliability and completeness of the data for these regions.This is particularly important as many high-ranking splice variants associated with neurodevelopmental disorders such as autism have been detected intronically [39].These findings suggest that whole genome sequencing, combined with highly effective tools for predicting the functional impact of variants that do not directly alter the amino acid sequence, would overcome the limitations of WES in detecting intronic and non-coding regions and could provide a more comprehensive understanding of the patient's disease profile.

Conclusions
We reported a microdeletion of 2.4 Mb in the 7p22.3region in an individual with neurodevelopmental disorder, epilepsy and congenital heart defect.Our report confirms the role of the 7p22.3region in neurodevelopmental delay, socio-emotional behavior and suggests further studies of potential candidate genes within the deletion in the pathogenesis of congenital heart defects and epilepsy.

Fig. 1
Fig. 1 Pedigree of the family included in the case study

Table 1
Summarized statistics for WES reads

Table 2
Summary of the affected genes and their associated diseases